549
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Sleep and neuropsychological performance in HIV+ subjects on efavirenz-based therapy and response to switch in therapy

, , , ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , , , , & show all

References

  • Maggiolo F. Efavirenz: a decade of clinical experience in the treatment of HIV. J Antimicrob Chemother. 2009;64:910–928.
  • Hawkins T, Geist C, Young B, et al. Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patients. HIV Clin Trials. 2005;6:187–196.
  • Fumaz CR, Munoz-Moreno JA, Molto J, et al. Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence. J Acquir Immune Defic Syndr. 2005;38:560–565.
  • Decloedt EH, Maartens G. Neuronal toxicity of efavirenz: a systematic review. Expert Opin Drug Saf. 2013;12:841–846.
  • Ciccarelli N, Fabbiani M, Di Giambenedetto S, et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology. 2011;76:1403–1409.
  • Ma Q, Vaida F, Wong J, et al. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol. 2016;22:170–178.
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540–545.
  • Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.
  • Table for Grading the Severity of Adult and Pediatric Adverse Events. November 2014. https://rsc.tech-res.com/docs/default-source/safety/table_for_grading_severity_of_adult_pediatric_adverse_events.pdf.
  • Wechsler D. Wechsler Adult Intelligence Scale-Fourth. San Antonio, TX: The Psychological Corporation; 2008.
  • Heaton RK, Grant, I, & Matthews, C.G. Comprehensive norms for an expanded Halstead-Reitan battery: demographic corrections, research findings, and clinical applications; with a supplement for the Wechsler Adult Intelligence Scale-Revised (WAIS-R). 1991.
  • Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–1799.
  • Mitterling T, Hogl B, Schonwald SV, et al. Sleep and Respiration in 100 Healthy Caucasian Sleepers–A Polysomnographic Study According to American Academy of Sleep Medicine Standards. Sleep. 2015;38:867–875.
  • Moyle G, Fletcher C, Brown H, Mandalia S, Gazzard B. Changes in sleep quality and brain wave patterns following initiation of an efavirenz-containing triple antiretroviral regimen. HIV Med. 2006;7:243–247.
  • Seay JS, McIntosh R, Fekete EM, et al. Self-reported sleep disturbance is associated with lower CD4 count and 24-h urinary dopamine levels in ethnic minority women living with HIV. Psychoneuroendocrinology. 2013;38:2647–2653.
  • Ellis RJ, Badiee J, Vaida F, et al. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy. AIDS. 2011;25:1747–1751.
  • Payne B, Chadwick TJ, Blamire A, et al. Does efavirenz replacement improve neurological function in treated HIV infection? HIV Med. 2017;18:690–695.
  • Veasey SC. Piecing together phenotypes of brain injury and dysfunction in obstructive sleep apnea. Front Neurol. 2012;3:139.
  • Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165:447–452.
  • Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–1384.
  • Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–1053.
  • Stone KL, Blackwell TL, Ancoli-Israel S, et al. Sleep disordered breathing and risk of stroke in older community-dwelling men. Sleep. 2016;39:531–540.
  • Mehra R, Stone KL, Varosy PD, et al. Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: outcomes of sleep disorders in older men (MrOS sleep) study. Arch Intern Med. 2009;169:1147–1155.
  • Beebe DW, Groesz L, Wells C, Nichols A, McGee K. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. Sleep. 2003;26:298–307.
  • Olaithe M, Bucks RS. Executive dysfunction in OSA before and after treatment: a meta-analysis. Sleep. 2013;36:1297–1305.
  • Nishiyama T, Mizuno T, Kojima M, et al. Criterion validity of the Pittsburgh sleep quality index and epworth sleepiness scale for the diagnosis of sleep disorders. Sleep Med. 2014;15:422–429.
  • Scarlata S, Pedone C, Curcio G, et al. Pre-polysomnographic assessment using the Pittsburgh sleep quality index questionnaire is not useful in identifying people at higher risk for obstructive sleep apnea. J Med Screen. 2013;20:220–226.
  • Kunisaki KM, Akgun KM, Fiellin DA, et al. Prevalence and correlates of obstructive sleep apnoea among patients with and without HIV infection. HIV Med. 2015;16:105–113.
  • Gingo MR, Balasubramani GK, Rice TB, et al. Pulmonary symptoms and diagnoses are associated with HIV in the MACS and WIHS cohorts. BMC Pulm Med. 2014;14:75.
  • Patil SP, Brown TT, Jacobson LP, et al. Sleep disordered breathing, fatigue, and sleepiness in HIV-infected and uninfected men. PLoS One. 2014;9:e99258.
  • Ng AK, Guan C. Impact of obstructive sleep apnea on sleep-wake stage ratio. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:4660–4663.
  • Gallego L, Barreiro P, del Rio R, et al. Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz. Clin Infect Dis. 2004;38:430–432.
  • Angarita GA, Emadi N, Hodges S, Morgan PT. Sleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive review. Addict Sci Clin Pract. 2016;11:9.
  • Palagini L, Baglioni C, Ciapparelli A, Gemignani A, Riemann D. REM sleep dysregulation in depression: state of the art. Sleep Med Rev. 2013;17:377–390.
  • Kryger M, Roth, T., Dement, W.C. Principles and Practice of Sleep Medicine. 6th ed. Philadelphia, PA: Elsevier, Inc; 2017:229–238.
  • Ju YS, Ooms SJ, Sutphen C, et al. Slow wave sleep disruption increases cerebrospinal fluid amyloid-beta levels. Brain. 2017;140:2104–2111.
  • Brown TT, Patil SP, Jacobson LP, et al. Anthropometry in the prediction of sleep disordered breathing in HIV-positive and HIV-negative men. Antivir Ther. 2010;15:651–659.
  • Brigham EP, Patil SP, Jacobson LP, et al. Association between systemic inflammation and obstructive sleep apnea in men with or at risk for HIV infection. Antivir Ther. 2014;19:725–733.
  • Darquenne C, Hicks CB, Malhotra A. The ongoing need for good physiological investigation: obstructive sleep apnea in HIV patients as a paradigm. J Appl Physiol. 2015;118:244–246.
  • Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med. 2008;9:425–432.
  • Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med. 1994;154:2219–2224.
  • Peppard PE, Austin D, Brown RL. Association of alcohol consumption and sleep disordered breathing in men and women. J Clin Sleep Med. 2007;3:265–270.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.